Publicaciones (404) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Adult height and risk of gastric cancer: A pooled analysis within the Stomach cancer Pooling Project

    European Journal of Cancer Prevention, Vol. 32, Núm. 3, pp. 215-221

  3. An Energy-Reduced Mediterranean Diet, Physical Activity, and Body Composition: An Interim Subgroup Analysis of the PREDIMED-Plus Randomized Clinical Trial

    JAMA network open, Vol. 6, Núm. 10, pp. e2337994

  4. Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort

    BMC Medicine, Vol. 21, Núm. 1

  5. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)

    Nature Genetics

  6. Blunted circadian variation of blood pressure in individuals with neurofibromatosis type 1

    Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1

  7. Carbon dioxide (CO2) emissions and adherence to Mediterranean diet in an adult population: the Mediterranean diet index as a pollution level index

    Environmental Health: A Global Access Science Source, Vol. 22, Núm. 1

  8. Case-fatality rate of SARS-CoV-2 infection during the third and fifth epidemic waves in Spain: Impact of vaccination (Pag.-e 102026)

    Semergen: revista española de medicina de familia, Núm. 7, pp. 5-5

  9. Clinical and economic impact of COVID-19 on people with obesity in a Spanish cohort during the first pandemic peak

    Frontiers in Endocrinology, Vol. 14

  10. Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study

    Frontiers in Cardiovascular Medicine, Vol. 10

  11. Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

    Biomedicine and Pharmacotherapy, Vol. 161

  12. Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain)

    International Journal of Cancer, Vol. 153, Núm. 5, pp. 979-993